BIOMAT Database Logo BIOMAT Database Logo

Semisynthetic cephamycins. II. Structure-activity studies related to cefmetazole (CS-1170). 1979

H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D002513 Cephamycins Naturally occurring family of beta-lactam cephalosporin-type antibiotics having a 7-methoxy group and possessing marked resistance to the action of beta-lactamases from gram-positive and gram-negative organisms. Antibiotics, Cephamycin,Cephamycin,Cephamycin Antibiotics
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
[Profile of cefmetazole (CS-1170) (author's transl)].
February 1979, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
Immunological studies on CS-1170, a new semisynthetic cephamycin antibiotic.
October 1978, The Japanese journal of experimental medicine,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
Cefmetazole (CS-1170): a new cephamycin with activity against gram-negative bacilli and staphylococci.
October 1982, The Journal of antimicrobial chemotherapy,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
[Massive cefmetazole (CS-1170) therapy for extremely severe respiratory infections (author's transl)].
August 1980, The Japanese journal of antibiotics,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
Review of the in-vitro spectrum and characteristics of cefmetazole (CS-1170).
April 1989, The Journal of antimicrobial chemotherapy,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
Cefmetazole (CS-1170), a "new" cephamycin with a decade of clinical experience.
January 1989, Diagnostic microbiology and infectious disease,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
Biological and chemotherapeutic studies on three semisynthetic cephamycins.
January 1978, The Journal of antibiotics,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
Antimicrobial activity of cefmetazole (CS-1170) and recommendations for susceptibility testing by disk diffusion, dilution, and anaerobic methods.
December 1986, Journal of clinical microbiology,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
[Laboratory and clinical studies CS-1170 (author's transl)].
March 1979, The Japanese journal of antibiotics,
H Nakao, and H Yanagisawa, and S Ishihara, and E Nakayama, and A Ando, and J Nakazawa, and B Shimizu, and M Kaneko, and M Nagano, and S Sugawara
[Pharmacokinetics and results of clinical administration of CS-1170. II. Results of clinical administration of CS-1170 (author's transl)].
January 1979, The Japanese journal of antibiotics,
Copied contents to your clipboard!